Ospedale S. Giovanni Bellinzona
Also known as: Bellinzona Hospital, Switzerland | Davide La Regina | Department of Anaesthesiology, Ospedale Regionale di Bellinzona e Valli-Bellinzona, CH-6500 Bellinzona, Switzerland | Institute of Oncology Research (IOR) | Institute of Southern Switzerland IOSI, Bellinzona | IOSI | IOSI, Bellinzona, Switzerland | IOSI Oncology Institute of Southern Switzerland | IOSI, Ospedale San Giovanni, Bellinzona | IOSI Sponsor Unit | Istituto Oncologico della Svizzera Italiana -6500 Bellinzona, Switzerland | Oncology Institute of Southern Switzerland | Oncology Institute of Southern Switzerland - Bellinzona, CH | Oncology Institute of Southern Switzerland, Bellinzona Hospital, 6500 Bellinzona, Switzerland | Oncology Institute of Southern Switzerland - Bellinzona, Switzerland | Oncology Institute of Southern Switzerland IOSI, Bellinzona | Oncology Institute of Southern Switzerland - Ospedale S. Giovanni Bellinzona CH | Ospedale Regionale Bellinzona e Valli | Ospedale Regionale di bellinzona e Valli | Ospedale San Giovanni Bellinzona
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2003Last known activity
Apr 28, 2025
Timeline
1300s
- Jun 1, 1300
Ospedale S. Giovanni Bellinzona— Founded
Drugs by trial phase (42 distinct, 27 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Embolism
- Endometrial Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Postoperative Pain
- Pulmonary Embolism
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Thrombosis
- Venous Thrombosis
Recent trials (42)
- NCT07002320CollaboratorPhase 1/Phase 2Apr 28, 2025
- NCT07002320CollaboratorPhase 1/Phase 2Apr 28, 2025
- NCT05748145Lead sponsorPhase 2Sep 11, 2023
- NCT04629781Study chairPhase 1May 28, 2021
- NCT04646395Study chairPhase 2Mar 15, 2021
- NCT04646395Study chairPhase 2Mar 15, 2021
- NCT04549428Reponsible party - principal investigatorPhase 2Oct 1, 2020
- NCT04549428Lead sponsorPhase 2Oct 1, 2020
- NCT04549428Overall official - principal investigatorPhase 2Oct 1, 2020
- NCT04456049CollaboratorPhase 2Jul 31, 2020
- NCT04400799CollaboratorPhase 3Jun 1, 2020
- NCT03886649Study chairPhase 1Jun 30, 2019
- NCT03708003Study chairPhase 2Mar 11, 2019
- NCT04575233Lead sponsorN/AJan 15, 2018
- NCT03274778Study directorN/ASep 1, 2017
Details
- Founded
- Bellinzona, CH Jun 1, 1300
- Last known activity
- Apr 28, 2025